Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Harry Balanta Murcia
Observed name:
Harry Balanta-Murcia
Institutions:
University Hospitals of Cleveland,
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
Case Western Reserve University
Observed institutions:
University Hospitals of Cleveland,
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
Case Comprehensive Cancer Center,
Case Western Reserve University
ORCID:
0000-0003-0494-3957
Observed ORCID:
0000-0003-0494-3957
OpenAlex ID:
A5072054957
Cost-effectiveness of CAR-T cell therapy compared to bispecific T-cell engagers in Relapsed/Refractory multiple myeloma: A retrospective study using a markov model
2025
·
Harry Balanta Murcia
, James Ignatz-Hoover
, et al.
·
Blood
·
1
PDF
Correlation Analysis of CD34+ Cell Counts between External Vendor and in-House Apheresis Testing to Support Laboratory Transition
2026
·
Harry Balanta Murcia
, Daniel Huey
, et al.
·
Transplantation and Cellular Therapy
CAR T-cell Consolidation Versus Lenalidomide Maintenance after Autologous Stem Cell Transplant in Multiple Myeloma: A Comparative Analysis of Toxicity and Cost
2026
·
Batoul Sadek
, Muhammad Saad Waqas
, et al.
·
Transplantation and Cellular Therapy
S3023 Hepatotoxicity From Anabolic Steroids: A Case of Ruptured Liver
2022
·
Abbinaya Elangovan
, Abigail Bacharach
, et al.
·
The American Journal of Gastroenterology
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type